Biorock Ventures
Emerging managerBuilt from this firm's Form D filings. The firm files no SEC adviser report.
- Website
- https://biorockventures.com
- HQ
- CA
Biorock Ventures makes seed-sized investments into private life science companies developing novel FDA regulated therapeutic drugs. Its portfolio page lists companies such as Immusoft, Vidya Therapeutics, AN2, Primmune Therapeutics, PTM Therapeutics, and Vaxcyte. Mary Wheeler is listed as Managing Director.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Biotech | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| BioRock Ventures Fund II, LP | 2025 | $2.9M to $60M (Form D) | Raising |
03 · People across funds
- Mary Wheeler, Member of the General Partner of the Issuer.
BioRock Ventures Fund II, LP (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026